The RARy gene generates two major isoforms, RARyl and RARy2, which originate from two distinct promoters. We report here the engineering of mice lacking RARyl, but in which RARy2 is normally expressed. The effect of this null mutation has been compared with those previously described for RARy2 and all RARy isoforms (total RARy gene inactivation), both in single mutants and in double mutants bearing additional null mutations in their RARa, RAR/3 or RXRCX genes. RARyl mutants, but not RARy2 mutants, displayed a subset of the abnormalities exhibited by total RARy null mutants (growth deficiency, abnormal cricoid cartilage and occasional cervical vertebra defects), suggesting that RARyl is the main isoform mediating the corresponding RARy functions. Interestingly, cricoid cartilage defects were also found in a fraction of heterozygote animals for the RARyl, RARy or RARa mutations, indicating that wild type levels of RARs are required for the normal morphogenesis of this structure. Compound RARcu/RARyl and RARtiARy2 double null mutants exhibited only a small fraction of the defects found in RAR&RARy double null mutants. Moreover, these defects were often partially penetrant, or corresponded to a less severe form. However, they occurred preferentially in certain compound mutants, demonstrating that given isoforms mediate specific functions of RARy in the context of a RARol null background. In a RXRor null background, both RARyl and y2 isoform mutations resulted in increased severity of the RXRo( null ocular phenotype. Together, the present observations indicate that the functions of the two RARy isoforms overlap to a large extent, but also that each of these isoforms exhibits a limited functional specificity. Furthermore, the occurrence of morphological defects in heterozygote mutants for a single RAR isoform provides a basis for explaining the strong conservation of these isoforms during vertebrate evolution. 0 1997 Elsevier Science Ireland Ltd.
Introduction
Vitamin A is important for many aspects of vertebrate physiology (Wolbach and Howe, 1925; see Spom et al., 1994 and Blomhoff, 1994 for reviews and references). Most notably, retinoids (the active metabolites of vitamin A) appear to play an essential role during mammalian development, as studies of rat fetuses from vitamin A deficient (VAD) dams revealed a large spectrum of abnormalities 132 V. Subbarayan et al. /Mechanisms of Development 66 (1997) [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] from, a variety of cognate response elements in vitro (Leid et al., 1992a ; for additional references and review, see Gronemeyer and Laude& 1995; Chambon, 1996) .
The multiplicity of retinoid receptors is further increased by the existence of several isoforms for each RAR and RXR isotype (see Leid et al., 1992b; Kastner et al., 1994a for reviews) . In the case of RARs, two promoters (Pl and P2) exist in each RAR gene, which direct the transcription of mRNAs encoding distinct isoforms with specific N-terminal sequences (the A region), and 5' untranslated (5' UTR) sequences (reviewed in Leid et al., 1992b and Kastner et al., 1994a) . Depending on the promoter from which they originate, RAR isoforms can be classified as type I (Pl promoter: RARa!l, RARPlIP3, RAR-rl) or as type II (P2 promoter: RARol2, RARP2, RARy2). Strikingly, the sequences specific to each isoform appear to be extremely well conserved during evolution, both in their coding and non-coding regions (for instance, a 100 bp stretch in the 5' UTR region of RARyl is identical in mouse and man, see Kastner et al., 1990) . These strong sequence conservations necessarily reflect an important selective pressure, which presumably indicates that mutations altering the A region amino acid sequence, and possibly features of the transcripts involved in the regulation of RNA stability and/or translational control (see Reynolds et al., 1996) are negatively selected in the course of evolution. Thus the various RAR isoforms may exert specific and important functions. Furthermore, analysis of the relative levels of individual isoform transcripts revealed tissue-specific patterns of expression which might reflect a functional specificity of the various RAR isoforms (Kastner et al., 1990; Gigubre et al., 1990; Leroy et al., 1991; Zelent et al., 1991) .
However, genetic analysis in knock-out mice of the functions of each individual RAR isotype, as well as of several isoforms (RARal, RAR/32, RARy2) , has shown that each of these receptors is dispensable for many of the biological RA-dependent events (Li et al., 1993; Lohnes et al., 1993; Lufkin et al., 1993; Mendelsohn et al., 1994a; Luo et al., 1995; Ghyselinck et al., 1997) . Furthermore, compound mutants bearing two mutations in distinct RARs are in general much more affected than the corresponding single mutants and, taken together, these double mutants recapitulate the complete spectrum of congenital defects of the fetal VAD syndrome (Lohnes et al., 1994; Mendelsohn et al., 1994b; Grondona et al., 1996; Luo et al., 1996; Ghyselinck et al., 1997) . Moreover, these compound RAR mutants exhibit also a large array of defects which have not been previously associated with vitamin A deficiency (see Kastner et al., 1995 for review) . Although these studies suggest a large degree of functional redundancy among the various RARs, other genetic data have suggested that the degree of specificity in the functions of each of these receptors may actually be much higher. Firstly, studies of RAR and RXR knockouts in the embryonal carcinoma cell line F9, combined with the use of synthetic receptor-selective agonists, have demonstrated RAR-specificity for the induction of distinct cellular events, as well as for the induction of expression of several target genes (Taneja et al., , 1996 and references therein; ' Chiba et al., 1997a,b; Roy et al., 1995; Clifford et al., 1996) . Secondly, the analysis of RXRc&AR compound mutant mice have shown that in a RXRa! mutant background, the different RARs exhibit a much higher functional specificity (Kastner et al., 1997) , suggesting that given RXR/RAR heterodimers actually transduce the RA signal to trigger different sets of biological events. The present study was aimed at investigating the individual contribution of the two major RARy isoforms (see Fig.  1 a) to the function of this receptor. Our previous analysis of RARy null mutants showed that the total inactivation of the RARy gene leads to several defects: marked growth deficiency, poor viability, hypoplasia or agenesis of the ocular Harderian glands, squamous keratinizing metaplasia of the prostate and seminal vesicles, malformations of cervical and thoracic vertebrae (including some homeotic transformations) and fusion of the tracheal cartilaginous rings . Furthermore, inactivation of RARy in either RARa, RARal, RARP, RAR/32 or RXRa mutant genetic backgrounds resulted in the appearance of a large set of defects, which include most of the abnormalities of the fetal VAD syndrome (Lohnes et al., 1994; Mendelsohn et al., 1994b; Kastner et al., 1994b Kastner et al., , 1997 Ghyselinck et al., 1997; see Kastner et al., 1995 for review) . In contrast, selective inactivation of the RARy2 isoform did not result in any obvious defect , whereas the absence of this isoform in a RAR/32 null background led to retinal abnormalities (Grondona et al., 1996) . Together, the marked difference between the large spectrum of defects resulting from the inactivation of all the RARy isoforms and the very limited effects of the inactivation of RARy2, raises the questions as to whether the RARyl isoform might be specifically mediating most of RARy functions, or whether the two RARy isoforms can exert common functions. We report here the selective inactivation of the RARyl isoform, and describe the effects of this mutation both in single mutants and in compound RARyl/RARa, RARylIRARP and RARylIRXRa! mutants. The phenotype of these mutants is compared with that of the corresponding compound RARy2IRAR and RARy2IRXR mutants.
Results

Inactivation of RARyl
We previously described the isoform-specific inactivation of RARy2, which was obtained with a positive/negative selection strategy (Capecchi, 1989) , and the use of a GT1/2-NE0 selection cassette inserted into exon E4 of the RARy gene (see Lohnes et al., 1993) . However, a similar strategy aimed at disrupting the RARyl isoform by using a vector in which this GT1/2-NE0 cassette was inserted into exon E3 (encoding the RARyl A region, see Fig. la ) of the same genomic subclone, failed to yield any ES cell clone having undergone homologous recombination (not shown). In order to enrich for homologous recombination events, we thus employed a 'promoter trap'-type vector, with a promoterless neomycin gene inserted into exon 3 (see Fig. lb ). Note that, since RARyl is expressed in ES cells (Kastner et al., 1990) , expression of the neomycin gene is expected to occur following homologous recombination.
This procedure drastically reduced the number of clones surviving the G418/ gancyclovir selection and, out of seven resistant ES cell clones, a single clone (FV5) had undergone the expected homologous recombination event (see Fig. lb ). Chimeras derived from this ES cell clone transmitted the mutation through their germline, and after intercrossing of the resulting heterozygous (RARyl+I-) mice, viable homozygotes (RAR-rl ' ) were obtained ( Fig. 2a; (Fig. 2b , lanes 3 and 4) or adult lung RNA (not shown). Furthermore, no amplification product could be generated from mutant RNA when primers specific for exons El or E2 were employed in combination with the ES-specific primer ( not shown). Therefore, even though El and E2 are still present in the mutant genome, possible transcripts resulting from the splicing of these exons to exon E5 are not produced, possibly owing to the presence of a polyadenylation signal in the NE0 cassette [see Fig. lb ; note also that we failed to amplify any product with NE0 and ES-derived primers (data not shown)]. In contrast, RARy2 transcripts could readily be amplified from RARyl-I-RNA at a level similar to that obtained from WT RNA (Fig. 2b , lanes 5 and 6, and data not shown). Thus, the present mutation selectively prevents the production of RARy proteins encoded by transcripts derived from the Pl, but not the P2 promoter. The absence of RARy l-related transcripts in mutant mice was also confirmed using an RNase protection assay with a RARy2 derived antisense probe spanning the RARy2 5' UTR and A region, and extending into the common B and C region sequences (Fig. 2c , see Lohnes et al., 1993 for further description of the probe). This experiment, which confirmed the absence of RARyl-derived transcripts in the mutants, showed furthermore that none of the RARy minor isoforms which are normally expressed at a very low level (y3 to ~6; see Kastner et al., 1990) , was up-regulated to any detectable levels in the mutants (Fig. 2b, lane 3) . In addition, semi-quantitative RT-PCR reactions showed that transcripts for RARa and RARP were present at normal levels in 12.5 dpc mutant embryos (data not shown), sug- RT-PCR analysis of wild type (+/+), heterozygotes (+/-) and homozygotes (-/-) total RNA from 12.5 dpc fetuses using sense primers from exons 1, 3 or 4, and an antisense primer from exon 5, as indicated. (c) RNase protection analysis of RNA from 12.5 dpc fetuses (lanes l-3) or 10.5 dpc embryos (lane 4; genotype indicated on top). The probe used corresponds to an antisense riboprobe spanning the sequences for the RAR72 5' untranslated and A region, and the common B and C regions (see Lohnes et al., 1993) . The histone H4 protection was included as an internal control for the quantitation and integrity of the RNA samples. The sizes of the protected fragments in each case is shown on the right. Note that, as no differences in the level of RARy2 expression is seen between WT and RARyI-'-embryos, the increased level of RARy2 transcripts in the RARyl+'-embryo (-2-fold) might correspond to normal variations of RARy2 expression among individual animals.
gesting therefore that no change in the expression levels of these receptors occurred following RARyl disruption.
Phenotype of RARyl null mutants
RARylmutants, which were recovered at the expected Mendelian frequency, were viable, fertile, and had a normal longevity. Thus, they did not show the reduced viability and male sterility of RARy null mutants. However, homozygous RAR? 1" mice exhibited a postnatal growth deficiency and, by 3 weeks of age, were on the average 10% smaller than their WT or RARy l+'-littermates (Fig. 3 , and data not shown). The RARyl mutation reproduces therefore a milder form of the growth deficiency phenotype displayed by RARy null mutants, which are typically 20-50% lighter than their WT littermates Look et al., 1995) . Note, however, that a few RARyl mutants exhibited a more pronounced growth deficiency, with weight reductions above 25% when compared to the average weight of heterozygote littermates (see Fig. 3 ). Growth deficiency was not observed in RARy2 null mutants (not shown).
RARy null mutants always exhibit axial skeletal defects, which predominate in the cervical region and include homeotic transformations . Defects of cervical vertebrae were detected in a few RARyl null mutants (3 out of 24; see Table 1 and Fig. 4b,c) . They consisted in malformations of C2 (bifidus; dysymphysis; enlarged neural arch; fusion with C3), as well as partial agenesis of the body of C4 (Fig. 4b , C4*) and C7 to C6 transformation (evidenced by the presence of a unilateral ventral tubercle on C7; 'TA' in Fig. 4b ). However, several defects frequently present in RARy null mutants were absent in the RARyl null mutants analysed, notably the presence of an ectopic anterior arch on C2 (which corresponds to a C2 to Cl transformation), fusion of the basioccipital bone to the anterior arch of the atlas, rib fusions, or the occurrence of eight vertebro-sternal ribs (see . As reported previously, RARy2 mutants did not exhibit any axial skeleton malformations (more than 30 skeletons analysed). Therefore, among RARy isoform-specific mutants, RARyl mutants selectively exhibit, at a low frequency, a subset of the vertebral abnormalities of RARy null mutants.
All RARy null mutants exhibit laryngeal and tracheal cartilaginous defects consisting in fusion between tracheal rings (Lohnes et al., 1993 and Fig. 4g) , and in the presence of a cartilaginous process extending caudally from the ventral side of their cricoid cartilage (see arrows in Fig. 4g and Table 2 ). RARyl mutant skeletons did not exhibit any tracheal ring fusions (Fig. 4f) . In contrast, the cricoid cartilage defect was present in a majority of these mutants (see Fig. 4f , and Table 2 ) and was even seen in a fraction of RAR-rl+/- (Fig. 4e) and RARy+/-animals ( Table 2 ). This defect was not observed in mice lacking RARy2, or WT mice (Table 2) . Interestingly, a ventral extention of the cricoid cartilage was also present in several RARo+/-and RARa-/-mutants (see Fig. 4h , and Table 2 ), as well as in 2 out of 3 15.5 dpc RXRo-/-skeletons (Fig. 4k, and Table 2 ). Therefore, the presence of a cricoid cartilage defect in various RAR or RXR deficient mice, including heterozygote mutants, indicates that morphogenesis of this laryngeal cartilage is highly sensitive to decreased levels of retinoid receptors (see Section 3).
Other features of the RARy null phenotype include partial or complete agenesis of the Harderian glands, keratinizing metaplasia of the epithelia of the prostate and seminal vesicles (which leads to male sterility) and interdigital webbing Kastner et al., 1997) . These defects were never observed in RARyl or RAR-r:! mutants (data not shown; Lohnes et al., 1993) .
We have previously shown that RARy, but not RARy2 mutants, were resistant to the lumbosacral truncation provoked by the administration of teratological doses of RA (100 mg/kg) at 8.5 dpc. When subjected to such a treatment, RARyl mutants exhibited similar lumbosacral truncations as their WT littermates (data not shown). Thus, neither RARy 1 nor RARy2 is uniquely involved in the mediation of this RA teratological effect. Offspring derived from intercrosses between RAR-yl"-and RARy I+'-mice were weighed at 3 weeks of age. To standardize for differences between litters, the weight of each animal was expressed as the ratio of its weight relative to the average weight of heterozygote animals within the same litter. Weight ratios were then grouped within classes differing from each other by a 0.05 increment (abscissa). Note that no weight difference was seen between heterozygotes and WT animals.
RARoJRARyl and RARcwBIR~Z double null mutants
Our previous studies showed that a RARy null mutation has a dramatic outcome in a RARa null genetic background, as RARa/RARy double null mutants exhibit a large spectrum of developmental defects (Lohnes et al., 1994; Mendelsohn et al., 1994b) . To investigate whether specific
RARy isoforms mediate the RARy functions in the absence of RARa, we introduced the RARyl or RARy2 mutations in a RARcx null mutant background. Both types of double mutants were analysed at 18.5 dpc on serial histological sections or whole mount skeletal preparations (Tables 2  and 3 ). Quite strikingly, these double mutants were much less severely affected than RAR&RARy null mutants, as Table 1 Axial skeletal abnormalities in RARyl, RARy2, RARcs single and double mutants
Genotype
Number of animals affected they lacked the majority of the defects arising in RARol/ RARy double mutants (such as ocular abnormalities, limb skeletal defect or heart defects). RARorlRARyl double null mutants were recovered at the expected Mendelian frequency in utero at 18.5 dpc. However, no double homozygote mutant was present among 52 surviving pups born from intercrosses between RARa+/-/ RARyl"-mice, indicating that they disappeared during the perinatal period, presumably as a consequence of selective cannibalisation by their mothers. In contrast, 3 RARa/ RARy2 double null mutants (out of 169 animals obtained from double heterozygote intercrosses) survived the perinatal period and reached adulthood. As no deficit in the number of these double mutants was observed in utero at 18.5 dpc, the low number of surviving animals suggests that the majority of these double mutants also disappeared around birth. Kidney hypoplasia was the most prominent defect in these double mutant.s, as it was completely penetrant in RARE-/RARy l-'-mutants and present in two-thirds of the RARcY ' /RAR@ mutants (Table 3) . Other defects observed at a low penetrance in either RAR&/ RARyl'-or RARa-'-IRARy2" mutants included: persistent truncus arteriosus (PTA), abnormalities of the great vessels derived from the aortic arches, Harderian gland agenesis, or presence of a cervical thymus (Table 3) . Given the low frequency of these latter defects, it is not possible to conclude whether they reflect isoform-specific functions.
Both RARaIRARyl and RARcJRARy2 double null mutants exhibited a clear increase in the frequency and severity of axial skeletal malformations when compared to the cognate single mutants, as 100% of these double mutants exhibited defects of their cervical vertebrae (Table 1 ). In addition, abnormalities were also observed in the thoracic and lumbar portions of the vertebral column (see Table 1 ). However, the magnitude of these vertebral defects never reached that of RAR&/RARyAdouble mutants (Lohnes et al., 1994) .
The ventral extension of the cricoid cartilage was markedly longer in RARa?/RARyl" (Fig. 4i , arrow) than in either RARcY or RARyl mutants. Since the severity of this malformation was not increased in RAR&/RARy2-'-mutants, RARyl may specifically mediate the function of RARy in the patterning of this cartilage. On the other hand, all RARaIRARy2 double null mutants exhibited abnormal extentions of both anterior horns of their thyroid cartilage which were fused to the hyoid bone (Fig. 4j, arrowheads) . Note that this fusion was found in RARa single null mutants and in RAR&/RARy Id-mutants, albeit at a low frequency in both cases Fig. 4i) . Thus, in a RARa! null genetic background, the two RARy isoforms clearly differentially contribute to the patterning of the laryngeal cartilages. (Table 3) , i.e. a cartilaginous or osseous extension fusing the incus to the alisphenoid bone, which corresponds to an atavistic feature (see Lohnes et al., 1994) . This supemumerary skeletal element occurred unilaterally with approximately the same frequency in RARa ' and RARol-'-I RARy?
mutants and data not shown). Thus, in a RARa null background, only mutation of RARy2 leads to an increased penetrance and expressivity of this feature. In contrast, the increase in the penetrance of the agenesis of the zygomatic process of the squamosal bone (Table 3) was similar in RARaIRARyl and RARnIRARy2 double null mutants.
RAR@RARyl double mutants
Four RAR@RARyl double null mutants were obtained (out of 23 mice derived from RAR/?/RARyl" intercrosses), which lived an apparently normal life. These mutants were sacrificed at age of 6 months and surprisingly, at autopsy, three out of these four mutants unilaterally lacked a kidney, probably as a consequence of hydronephro- sis (data not shown). As RARp/RARy2 double mutants have not been generated, it is presently unclear whether this phenotype reflects a specific function of RARyl in the context of a RAR/3 null background. Note, however, that RARP2IRARy2 double mutants did not display this defect. These latter mutants, on the other hand, exhibit retinal dysplasia and degeneration (Grondona et al., 1996) , which were absent in the 8 RAR/3_I-/RARyl" eyes that were examined.
RXRwBARyl and RXRaYRARy2 double mutants
We have previously reported a synergy between the effects of the RARy and RXRa mutations:
(i) several defects not occurring in single mutants (persistent trnncus arteriosus, aortic arch abnormalities, Mtillerian duct agenesis, submandibular gland hypoplasia; see Kastner et al., 1997) were present in RXRa/RARy double null mutants; (ii) the anterior eye segment malformations of the RXRa null mutants (thicker cornea and closer position of the eyelids) was dramatically enhanced in RXRa/RARy double null mutants in which structures of the eye anterior segment were replaced by a thick layer of undifferentiated mesenchyme (Kastner et al., 1994b (Kastner et al., , 1997 . Interestingly, inactivation of only one of the two alleles of the RARy gene in a RXRa, null background already led to an increase in the severity of the RXRo null mutant eye phenotype (Kastner et al., 1994b) .
Two RXRolIRARyl and two RXRoIRARy2 double null mutants were analysed at 14.5 dpc. Both RXRol ' / RARyl-I-and one RXRa?/RARy2-Imutants displayed an increased severity of the RXRa! null ocular phenotype, which was comparable with that of RXRa ' /RARy+'-mice (not shown). This observation indicates that both RARy isoforms contribute to the RARy function in patterning the anterior segment of the eye. With this exception, RXR&/RARyl~-and RXRo"-IRARy2" fetuses were in-distinguishable from RXRol single null mutants.
3. Discussion
The functions of RARyl and RARy2 are largely overlapping
The present RARyl isofonn-specific mutation represents the third type of mutant allele generated at the RARy locus. The availability of both a 'total' isotype null allele and alleles specifically disrupting either one of the two major isoforms allows, for the first time, to genetically address the respective contributions of given isoforms to the total function of a RAR. Clearly, the effects of either the RARyl or RARy2 isoform-specific mutations are markedly weaker than those of the total RARy inactivation: no defects have been up to now found in RARy2 mutants and RARy 1 mutants do not exhibit most of the defects of RARy null mutants. In addition, the defects observed in RARyl mutants were either milder (growth deficiency) or had a reduced penetrance (cricoid cartilage and cervical vertebra defects) when compared with the corresponding defects of RARy null mutants. Furthermore, in the context of RARo, RARP or RXRa mutant genetic backgrounds, the effects of the RARy isoform-specific mutations were always much less drastic than those of the RARy total mutation, as inactivation of either RARyl or RARy2 failed to generate most of the defects arising from a RARy mutation, or led to defects with a reduced penetrance (PTA, aortic arch abnormalities) or severity (cervical vertebra defects). Thus, in most cases, the presence of a single isoform appears to be sufficient to perform the function of RARy, at least in so far as can be judged from the absence of overt morphological defects. This functional overlap probably results from an overlap of the expression domains of the two RARy isoforms, as (i) when tested for isoform specific expression, all cell line or tissue samples expressing RARy transcripts also contained both RAR-yl and RARy2 transcripts, albeit at different relative levels (Kastner et al., 1990) and (ii) in situ hybridisation studies performed on embryo sections with RARyl or RARy2 isoform specific probes failed to reveal any clear distinct expression patterns of these isoforms (our unpublished results). Thus, the most likely explanation for this functional overlap is that RARyl and RARy2 could be widely redundant for the control of similar molecular events, even though we cannot formally exclude alternative scenarios, in which the two isoforms might for instance control distinct events, both of which have to be abrogated to generate a given morphological defect.
Limited specificity for RARyl and RARy2
Nevertheless, our results point to some degree of functional specificity for each isoform. The lack of RARy 1, but not of RARy2, results in growth deficiency, cricoid cartilage dysmorphogenesis and cervical vertebra malformations. Thus, RARyl appears to be the major RARy isoform mediating the corresponding RARy functions, even though the reduced penetrance and/or severity of these defects suggest that these RARyl functions can be partially compensated for by RARy2. Likewise, in a RAR/32 (or RARP) null mutant background, only mutation of RARy2, but not of RARyl, leads to retinal dysplasia and degeneration (Grondona et al., 1996) . Conversely, only RAR&RARyl double mutants, but not RARaIRARy2 double mutants, exhibit a marked increase in the severity of the cricoid cartilage malformation. Together, these observations indicate that a given RARy isofomr preferentially mediates the RARy function in a limited number of RA-dependent processes.
It is important to stress that the appearance of a defect in double mutants lacking a given RARy isoform and another RAR does not necessarily mean that RARy isoform plays a physiological role in the corresponding process. For instance, our previous studies of RARa single mutants and RXR&RAR compound mutants Kastner et al., 1997) have clearly shown that defects such as kidney hypoplasia, abnormal anterior horns of the thyroid cartilage or presence of a pterygoquadrate element, mainly result from the abrogation of the function of RARcY. Thus, the occurrence of these defects in RARaIRARy 1 or RARa/ RARy2 double null mutants might reflect a compensatory function for these RARy isoforms in the artefactual situation of the RARo knockout, rather than a physiological role for these isoforms in the corresponding processes. In any event, the occurrence of distinct defects in RARaIRARyl and RARoIRARy2 null mutants indicates that RARyl and RARy2 are not functionally equivalent.
Whether the few RARy isoform-specific functions reflect a limited specificity in their expression patterns or some specificity of the transcriptional activity of their isoform-specific N-terminal A region, is unknown. In this respect, we note that Brockes and coworkers have recently demonstrated that in regenerating newt limb blastema cells, expression of chimeric receptors containing specific RARa! 1, RARy 1 or RARy N-terminal sequences fused to the ligand binding domain of the thyroid hormone receptor results in different T3-dependent responses (Schilthuis et al., 1993; Pecorino et al., 1994 Pecorino et al., , 1996 , possibly indicating that the isoform-specific N-terminal A region of the various RARs may mediate specific functions in vivo. Thus, given the conservation of some sequence features of these A regions across vertebrates (Kastner et al., 1994a) , the unique functional properties of the newt RARy A regions may have persisted in their mouse homologs.
Defects in RARyl heteroqgotes: evolutiona? in&cations
Our present data indicate that the normal morphogenesis of the cricoid cartilage can be perturbed in several cases of mild receptor deficiencies. Abnormal cricoid cartilage arises not only in most RARyl ' mutants, but also in some RARy+'-, RARyl+'-or RARa+'-animals. The fact that a biological process can be perturbed by heterozygocity of RAR isotype or isoform mutations indicates that WT levels of receptors are physiologically required in some instances to ensure the transduction of the RA signal. It might be argued that such 'mild' defects could be sufficient to account for the conservation of RAR isoforms, as they may confer a selective disadvantage to animals subjected to natural selection forces, even though they may not overtly affect the life of an animal in a protected laboratory environment. Whether the cricoid cartilage defect described in the present study can confer such a disadvantage is not known. In any event, the mere presence of defects in a significant fraction of heterozygote RAR mutants should be considered as a paradigm, suggesting that additional defects not yet characterized may result from RAR heterozygocity. Such defects, which might not lead to overt morphological malformations, could nevertheless reduce the 'fitness' of affected animals. Thus, as in a natural population, the number of individuals heterozygote for a mutation in a given gene exceeds by far the number of individuals with both alleles mutated, even slight deleterious effects of heterozygous mutations may constitute the main evolutionary driving force responsible for the conservation of the sequences of a given receptor isoform, as well as of their untranslated sequences (which may be involved in controling the levels of protein produced; see Reynolds et al., 1996 for instance).
We have also previously shown that, in a RXRa+'-genetic background, heterozygocity for RARa, RARP or RARy can lead to a number of defects, including cervical vertebra dysmorphogenesis, digital webbing or presence of a retrolenticular membrane (Kastner et al., 1997) . These observations indicate that the deleterious effects of RAR heterozygote mutations can become enhanced by epistatic interactions within certain genetic backgrounds. Such interactions will obviously increase the selective power of heterozygocity at a given RAR locus.
Most RA-dependent events resist drastic receptor dejiciencies
In contrast to rare events which critically require the presence of a full set of RARs, most RA-dependent developmental processes appear to be resistant to drastic receptor deficiencies. since their impairment often require the combined absence of two RARs, or one RAR and RXRo (Lohnes et al., 1994; Mendelsohn et al., 1994b; Luo et al., 1996; Ghyselinck et al., 1997; Kastner et al., 1997) . The present results further show that in the absence of either RARcu, RAR/3 or RXRa, the presence of a single RARy isoform is sufficient to rescue most events which are perturbed in the corresponding double mutants bearing the RARy null mutation. Thus, in addition to suggesting a lack of specificity in the functions of these isoforms, these observations also indicate that complete absence of all RARy isoforms may be required in these various genetic backgrounds to impair most RA-dependent events. Similariy, either the RARcvl or RARcu2 isoform alone can replace in most instances RARa, as RARal/RARy and RARo2/RARy double mutants are much less affected than the RARaIRARy double mutants (Lohnes et al., 1994; Mendelsohn et al., 1994b; R. Taneja and PC, unpublished data) . These observations probably indicate that all RARs, which originate by duplication from the same ancestral gene, are still close enough to be able to functionally replace each other in many instances, albeit possibly with different efficiencies. Thus, most of the effects of a given RAR gene knockout may not become apparent as long as a critical threshold level of RARs is present, and be revealed only in double RAR mutants. Note, however, that these functional redundancies may not reflect the physiological situation, but rather the artefactual new situation generated by the gene knockout, as we have previously shown that at least some functional redundancies revealed by knockout studies do not operate under wild type physiological conditions, when all RARs are expressed (Taneja et al., 1996; Chiba et al., 1997a,b) . Thus, at least in the case of multigene families, gene knockouts may often fail to reveal most of the actual functions of a given gene product in the wild type animal.
Materials and methods
RARyl targeting vector and homologous recombination
The targeting vector has been derived from approximately 6 kb of genomic sequences from the RARy locus, extending from a Sac11 site (present in exon 1, see Fig. 1 b) to a KpnI site (located 1.3 kb downstream of exon 3), which were inserted into BluescriptSK+. In this plasmid, a cassette containing a promoterless neomycin resistance gene and a polyadenylation signal from the PGK gene was inserted between the RARyl ATG (in exon 3) and the XbaI site (in the intron following exon 3; see Fig. 1 ). In this vector, the sequence surrounding the neo initiation codon is AGC-TACGGCCGCACCATG...
(original bases from exon 3 in italic). A GTL-2/TK cassette (Lufkin et al., 1992) was subsequently inserted at the 5' site of this vector as a Not1 fragment. This final targeting vector was linearised with XhoI prior to electroporation into Pl ES cells (an unpublished 129&v-derived ES cell line established in our laboratory). Clones surviving the neomycin/gancyclovir selection (Lufkin et al., 1991) were expanded, their DNA extracted and analysed by Southern blotting with a 3' external probe (a 700 bp KpnI-SphI fragment) following BglII digestion. Further analysis with a NEO-derived probe confirmed that no other integration of the vector had occurred.
Mutant mice
RARa, RAR& RARy, RARy2 and RXRa! mutant mice were described previously (Kastner et al., 1994b; Lufkin et al., 1993; Ghyselinck et al., 1997) .
RNA analysis
Total RNA was prepared from either 12.5 dpc embryos or adult lung tissues by the single step guanidinium-isothiocyanate-phenol technique (Chomczynski and Sacchi, 1987) with the addition of a second phenol chloroform extraction step. For RT-PCR, reverse transcription was performed using AMV reverse transcriptase at 50°C for 15 min, followed by a PCR reaction. Thirty-five cycles were performed, consisting of 1 min at 94°C 30 s at 55°C (El-E5 and E3-E5 primer pairs), or 60°C @l-E5 primer pair), and 1 min at 72°C. The following exon-specific primers were: El, 5'-CCATTACCGCGAGTCACTAA; E3, Y-ACTGGACA-GACCAGGCAG; E4, 5'-TGCTTCGCCGGACTTG; E5, 5'-TGGCTTATAGACCCGAGGAGGTGGT.
PCR reactions were separated on 1.5% agarose gels, transferred to a nylon membrane and hybridised with an end-labeled oligonucleotide derived from exon 5 (5'-ACTCCCTCTC-GACCCATGGT).
For RNase protection experiments, approximately 50 pg of total RNA was used. The probes and the conditions for the preparation of antisense riboprobes and hybridisation were previously described .
4.4, Histological and skeletal analysis
For whole-mount skeletal analysis, newborn fetuses were collected and skeletons were prepared as previously described (Lufkin et al., 1992) . For histological analysis, fetuses were skinned and then fixed in Bouin's solution. Paraffin sections, 7 pm thick, were stained with Groat's hematoxylin and Mallory's trichrome .
